Show simple item record

dc.contributor.authorDaly, Jennifer S.
dc.contributor.authorWorthington, Michael G.
dc.contributor.authorBrenner, Don J.
dc.contributor.authorMoss, C. Wayne
dc.contributor.authorHollis, Dannie G.
dc.contributor.authorWeyant, Robbin S.
dc.contributor.authorSteigerwalt, Arnold G.
dc.contributor.authorWeaver, Robert E.
dc.contributor.authorDaneshvar, Maryam I.
dc.contributor.authorO'Connor, Steven P.
dc.date2022-08-11T08:09:30.000
dc.date.accessioned2022-08-23T16:33:35Z
dc.date.available2022-08-23T16:33:35Z
dc.date.issued1993-04-01
dc.date.submitted2008-10-31
dc.identifier.citationJ Clin Microbiol. 1993 Apr;31(4):872-81.
dc.identifier.issn0095-1137 (Print)
dc.identifier.pmid7681847
dc.identifier.urihttp://hdl.handle.net/20.500.14038/38140
dc.description.abstractA Rochalimaea-like organism (strain F9251) was isolated from a patient with endocarditis after blood drawn for culture before antimicrobial therapy was subcultured onto blood and chocolate agars and incubated for 2 weeks in 5% CO2. The strain was phenotypically similar to known Rochalimaea species. The cellular fatty acid composition of strain F9251 was close to but distinct from those of the three known Rochalimaea species and was most similar to that of R. vinsonii. Labeled DNA from strain F9251 was 59 to 67% related to DNAs from type strains of the three described Rochalimaea species, and its 16S rRNA gene sequence was 98.9% or more homologous to their 16S rRNA gene sequences. These findings support classification of F9251 as a new Rochalimaea species, for which the name Rochalimaea elizabethae sp. nov. is proposed. The patient infected with the organism had large bacterial vegetations on his aortic valve and was cured with antibiotics and valve-replacement surgery. Recognition of the procedures required to identify this and other Rochalimaea species suggests that clinical laboratories should prolong the incubation times of cultures of blood and tissue from patients with suspected endocarditis, patients with fever of unknown origin, and immunocompromised patients with fever so that the full spectrum of disease caused by these organisms can be recognized.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=7681847&dopt=Abstract">Link to Article in PubMed</a>
dc.subjectAdult
dc.subjectBase Composition
dc.subjectBase Sequence
dc.subjectDNA, Bacterial
dc.subjectEndocarditis, Bacterial
dc.subjectFatty Acids
dc.subjectHumans
dc.subjectMale
dc.subjectMolecular Sequence Data
dc.subjectPhenotype
dc.subjectRNA, Bacterial
dc.subjectRNA, Ribosomal, 16S
dc.subjectRickettsiaceae
dc.subjectRickettsiaceae Infections
dc.subjectMedical Microbiology
dc.titleRochalimaea elizabethae sp. nov. isolated from a patient with endocarditis
dc.typeJournal Article
dc.source.journaltitleJournal of clinical microbiology
dc.source.volume31
dc.source.issue4
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=2023&amp;context=oapubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/1024
dc.identifier.contextkey659209
refterms.dateFOA2022-08-23T16:33:35Z
html.description.abstract<p>A Rochalimaea-like organism (strain F9251) was isolated from a patient with endocarditis after blood drawn for culture before antimicrobial therapy was subcultured onto blood and chocolate agars and incubated for 2 weeks in 5% CO2. The strain was phenotypically similar to known Rochalimaea species. The cellular fatty acid composition of strain F9251 was close to but distinct from those of the three known Rochalimaea species and was most similar to that of R. vinsonii. Labeled DNA from strain F9251 was 59 to 67% related to DNAs from type strains of the three described Rochalimaea species, and its 16S rRNA gene sequence was 98.9% or more homologous to their 16S rRNA gene sequences. These findings support classification of F9251 as a new Rochalimaea species, for which the name Rochalimaea elizabethae sp. nov. is proposed. The patient infected with the organism had large bacterial vegetations on his aortic valve and was cured with antibiotics and valve-replacement surgery. Recognition of the procedures required to identify this and other Rochalimaea species suggests that clinical laboratories should prolong the incubation times of cultures of blood and tissue from patients with suspected endocarditis, patients with fever of unknown origin, and immunocompromised patients with fever so that the full spectrum of disease caused by these organisms can be recognized.</p>
dc.identifier.submissionpathoapubs/1024
dc.contributor.departmentMedical Center of Central Massachusetts
dc.source.pages872-81


Files in this item

Thumbnail
Name:
7681847.pdf
Size:
2.748Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record